ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,101.25
0.50%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. C4 Therapeutics Inc (CCCC)

  7. C4 Therapeutics Inc (CCCC) Noticias

CCCC C4 Therapeutics Inc

6.16
-0.64 (-9.41%)
10 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
C4 Therapeutics Inc CCCC NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.64 -9.41% 6.16 23:00:13
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
6.85 6.15 6.935 6.16 6.80
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/5/202406:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202406:07EDGAR2Form 8-K - Current report
08/5/202406:00GLOBEC4 Therapeutics Reports First Quarter 2024 Financial Results..
29/4/202415:01GLOBEC4 Therapeutics Announces Inducement Grant Under Nasdaq..
09/4/202406:00GLOBEC4 Therapeutics to Participate in the Stifel 2024 Targeted..
08/4/202407:00GLOBEC4 Therapeutics Presents New Preclinical Data for CFT1946..
08/3/202418:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202418:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202418:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202418:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202418:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:10EDGAR2Form 8-K - Current report
05/3/202415:30GLOBEC4 Therapeutics to Present New Preclinical Data on Highly..
04/3/202406:05EDGAR2Form 8-K - Current report
04/3/202406:00GLOBEC4 Therapeutics Announces Strategic Discovery Research..
22/2/202408:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202406:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202406:15EDGAR2Form 8-K - Current report
22/2/202406:00GLOBEC4 Therapeutics Reports Fourth Quarter and Full Year 2023..
15/2/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202409:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/2/202408:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/1/202415:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/1/202406:05EDGAR2Form 8-K - Current report
09/1/202415:06EDGAR2Form 8-K - Current report
09/1/202415:01GLOBEC4 Therapeutics Announces 2024 Priorities and Extended Cash..
04/1/202415:01GLOBEC4 Therapeutics Announces Closing of $25 Million Equity..
04/1/202406:00GLOBEC4 Therapeutics to Present at the 42nd Annual J.P. Morgan..
03/1/202415:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202315:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/12/202315:28EDGAR2Form 8-K - Current report
12/12/202315:01GLOBEC4 Therapeutics Announces Positive Data from CFT7455 Phase 1..
12/12/202308:15APSBiotech Catches Major Premarket Bid
12/12/202306:15EDGAR2Form 8-K - Current report
12/12/202306:00GLOBEC4 Therapeutics Announces License and Research Collaboration..
28/11/202306:00GLOBEC4 Therapeutics to Host Webcast to Present New Dose..
20/11/202306:05EDGAR2Form 8-K - Current report
20/11/202306:00GLOBEC4 Therapeutics Strengthens Board of Directors with Owen..
13/11/202315:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/11/202306:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202306:18EDGAR2Form 8-K - Current report
01/11/202306:00GLOBEC4 Therapeutics Reports Third Quarter 2023 Financial Results..
11/10/202306:00GLOBEC4 Therapeutics Announces Upcoming Data Presentations for..
03/10/202315:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
CCCC
C4 Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados